D. Gheta

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2021, RMD Open.

An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries.

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2021, European heart journal. Cardiovascular pharmacotherapy.

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2022, International journal of cardiology. Heart & vasculature.

Correspondence to: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al

D. Kane, R. Mullan, R. Conway, 2020, Annals of the Rheumatic Diseases.

Urate-lowering therapy (ULT) reduces non-episodic foot pain in patients who fail to meet ACR/EULAR 2015 gout classification criteria: an effect predicted by ultrasound and potential rationale for reclassification

D. Kane, R. Mullan, G. Boran, 2018, Annals of the rheumatic diseases.